英国国家指南变更对疫情期间妊娠期糖尿病筛查的影响:一项单中心观察性研究
该单中心观察性研究比较了NICE推荐方法与RCOG疫情期间建议的妊娠期糖尿病检出率。采用RCOG指南后,检出率从7.7%(1853/24168)降至4.2%(35/831)(P=0.0003)。在230例按RCOG标准阴性后行口服葡萄糖耐量试验的妇女中,47例(20.4%)按NICE标准诊断为妊娠期糖尿病。
要点
- RCOG疫情期间筛查方案使GDM检出率从7.7%降至4.2%(P=0.0003)。
- 按RCOG标准阴性的230例中,47例(20.4%)经OGTT按NICE标准诊断为GDM。
- 作者结论:RCOG方案漏诊47/82(57%)后续确诊的GDM,不能推荐常规使用。
核心结论
- 在本研究机构中,RCOG Covid-19妊娠期糖尿病筛查方案漏诊了47/82(57%)后续被确定为妊娠期糖尿病的妇女,因此不能推荐常规使用。
研究设计与样本
- 研究为对2016年1月1日至2020年7月1日分娩妇女的队列研究,采用前瞻性收集数据的回顾性分析。
- 研究场所为伦敦教学医院,人群为2016年1月1日至2020年5月13日所有分娩妇女,并随访2020年4月1日至2020年5月13日筛查阴性者。
主要发现
- 采用RCOG指南后,被识别为妊娠期糖尿病的总体比率从7.7%(1853/24168)降至4.2%(35/831)(P=0.0003)。
- 2020年4月1日至5月13日按RCOG标准检测为阴性的230例妇女中,后续行口服葡萄糖耐量试验者47例(20.4%)按NICE标准诊断为妊娠期糖尿病。
临床怎么用
- 作者结论认为RCOG Covid-19妊娠期糖尿病筛查方案不能推荐常规使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the differences in detection rate for gestational diabetes (GDM) comparing the methodology recommended by the National Institute for Health and Clinical Excellence (NICE) compared with testing described as appropriate during the Covid-19 pandemic by the Royal College of Obstetricians and Gynaecologists (RCOG). DESIGN: Cohort study of women delivering between 1 January 2016 and 1 July 2020. SETTING: London Teaching Hospital. POPULATION: All women delivering between 1 January 2016 and 13 May 2020 and follow up of women screening negative between 1 April 2020 and 13 May 2020. METHODS: Retrospective study of prospectively collected data. MAIN OUTCOME MEASURES: Detection rate of gestational diabetes. RESULTS: Using the RCOG guidance, the overall rate of women identified as having gestational diabetes fell from 7.7% (1853/24168) to 4.2% (35/831)(P = 0.0003). Of 230 women who tested negative according to the RCOG criteria from 1 April to 13 May but who subsequently had an oral glucose tolerance test, 47 (20.4%) were diagnosed as having gestational diabetes according to the NICE criteria. CONCLUSIONS: In our setting, the RCOG Covid-19 gestational diabetes screening regime failed to detect 47 of 82 (57%) women subsequently identified as gestational diabetics, and therefore cannot be recommended for general use. TWEETABLE ABSTRACT: Screening for GDM using RCOG Covid criteria reduced detection rates.
引用
- van-de-l'Isle Y, Steer PJ, Watt Coote I, et al. Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study. BJOG. 2020. PMID: 32888369. doi:10.1111/1471-0528.16482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。